Furthermore, using the public database, we found that EGFR was significantly overexpressed in the following subgroups: squamous cell carcinoma, previously received radiation therapy, non-Barretts esophagus, BMI ≤25, alive patients, and non-columnar metaplasia (P < 0.05, Figure 3). Here, EGFR is linked to esophageal adenocarcinoma.